A PLACEBO-CONTROLLED TRIAL OF MEMANTINE AS AN ADJUNCT TO INJECTABLE EXTENDEDRELEASE NALTREXONE FOR OPIOID DEPENDENCE

There is preclinical support for using NMDA receptor glutamatergic antagonists to aid in naltrexone-based treatment of opioid dependence. We hypothesized that adding memantine will improve efficacy of extended-release (XR) naltrexone to prevent relapse. In this double blind study opioid-dependent pa...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Bisaga, Adam, Sullivan, Maria A., Glass, Andrew, Mishlen, Kaitlyn, Carpenter, Kenneth M., Mariani, John J, Levin, Frances R., Nunes, Edward V.
Формат: Artigo
Язык:Inglês
Опубликовано: 2014
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007510/
https://ncbi.nlm.nih.gov/pubmed/24560438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2014.01.005
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы